EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CRISPR‐Cas9‐Loaded Theranostic Liposomes for Enhancing Radiosensitization of Prostate Cancer through POLD4 Gene Editing under Real‐Time MRI Monitoring

Xuhui Fan, Ruru Zhang, Linjun Yang, Shixiong Chen, Meijuan He, Yongqiang Wang, Linjie Huang, Jianfeng Zeng, Shuwang Wu, Mingyuan Gao, Han Wang iD

Advanced Science · 2026-03 · 13 (16)

DOI: 10.1002/advs.202519704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 07.01.2026. Verfasst von Xuhui Fan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Liposomes, Magnetic Resonance Imaging, CRISPR-Cas Systems. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Hospital Development Center, Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy is a fundamental treatment for prostate cancer; however, its therapeutic efficacy is frequently limited by radioresistance mediated through DNA repair mechanisms and other biological factors. Although gene therapy holds promise for overcoming such resistance, identifying effective radiosensitization targets and developing efficient gene delivery systems remain practically challenging. In this study, transcriptomic analysis of radiotherapy‐treated prostate cancer cells revealed a marked upregulation of DNA polymerase delta subunit 4 (POLD4), a target that has not been systematically studied. To evaluate the potential of POLD4 for overcoming radioresistance, CRISPR‐Cas9‐based plasmids along with ultrasmall superparamagnetic iron oxide nanoparticles (USPIONs) were encapsulated within cationic liposomes for achieving an MRI‐trackable gene delivery platform (plasmid and iron oxide co‐loaded liposomes, termed PIO@Lipo). Comprehensive in vitro and in vivo studies demonstrated that PIO@Lipo enabled efficient POLD4 knockdown. Furthermore, PIO@Lipo synergized with radiotherapy to induce extensive DNA damage, promote tumor cell apoptosis, and remodel the immunosuppressive microenvironment. Notably, PIO@Lipo displayed superior MRI contrast enhancement capability and passive tumor targeting ability. In conclusion, this study has identified POLD4 as a potent target for radiosensitization, capable of disrupting DNA damage‐repair homeostasis through MRI‐monitored gene editing, thereby offering a promising strategy to enhance the efficacy of radiotherapy in prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsLiposomesMagnetic Resonance ImagingCRISPR-Cas SystemsGene EditingTheranostic NanomedicineMaleHumansAnimalsCell Line, TumorMiceRadiation ToleranceGenetic Therapy

Stichwörter der Autor:innen

DNA repairlipid nanoparticlesmagnetic resonance imagingprostate cancerradiosensitization

Substanzen

Liposomes

Autor:innen und Institutionen

  • Department of Radiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions,…
  • Department of Bone and Joint Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • School of Life Sciences, Suzhou Medical College, Soochow University, Suzhou, P. R. China.
  • Shanghai General Hospital Branch of National Center for Translational Medicine (Shanghai), Shanghai, P. R. China.
  • Jiading Branch of Shanghai General Hospital, Shanghai, P. R. China.

ORCID-Profile: Han Wang

Förderung

  • Shanghai Municipal Hospital Development Center
  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China
  • Major Program of Shanghai Municipal Commission of Education

Zitieren

APA

Fan, X., Zhang, R., Yang, L., Chen, S., He, M., Wang, Y., Huang, L., Zeng, J., Wu, S., Gao, M., & Wang, H. (2026). CRISPR‐Cas9‐Loaded Theranostic Liposomes for Enhancing Radiosensitization of Prostate Cancer through POLD4 Gene Editing under Real‐Time MRI Monitoring. Advanced Science, 13(16). https://doi.org/10.1002/advs.202519704

Vancouver

Fan X, Zhang R, Yang L, Chen S, He M, Wang Y, et al. CRISPR‐Cas9‐Loaded Theranostic Liposomes for Enhancing Radiosensitization of Prostate Cancer through POLD4 Gene Editing under Real‐Time MRI Monitoring. Advanced Science. 2026;13(16). doi:10.1002/advs.202519704

BibTeX
@article{Fan2026,
  author = {Fan, Xuhui and Zhang, Ruru and Yang, Linjun and Chen, Shixiong and He, Meijuan and Wang, Yongqiang and Huang, Linjie and Zeng, Jianfeng and Wu, Shuwang and Gao, Mingyuan and Wang, Han},
  title = {CRISPR‐Cas9‐Loaded Theranostic Liposomes for Enhancing Radiosensitization of Prostate Cancer through POLD4 Gene Editing under Real‐Time MRI Monitoring},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {16},
  doi = {10.1002/advs.202519704}
}
Kostenlos starten →